Phosphonic diesters for the treatment of diabetes and hyperlipidaemia

Abstract

This Otsuka Pharm patent discloses a phosphonic diester derivative and claims that a medicine containing this ingredient could be used for treatment of patients with diabetes mellitus and hyperlipidaemia. The compound is the first phosphonic ester derivative disclosed with the potential to reduce blood sugar and lipid levels.